STOCKWATCH
·
Healthcare Research- Analytics & Technology
Quarterly Result29 Jan 2026, 06:55 pm

Indegene Reports Strong Q3 FY26 Performance with 30%+ YoY Revenue Growth

AI Summary

Indegene, the tech-native, life sciences specialist, announced its financial results for the quarter ended December 31, 2025. The company achieved revenue of INR 9,421 million, reflecting 30.8% growth YoY & 17.1% growth QoQ. Indegene maintained a strong profitability profile, with an adjusted EBITDA of INR 1,747 million, growing 15.7% YoY & 19.6% QoQ. The company crossed a few key milestones in Q3, including the first $100+ million quarterly revenue and revenue per employee (RPE) crossing $70k. Indegene also secured several breakthrough deal wins with customer contracts exceeding $10 million ACV each.

Key Highlights

  • Achieved revenue of INR 9,421 million, reflecting 30.8% growth YoY & 17.1% growth QoQ
  • Maintained a strong profitability profile, with an adjusted EBITDA of INR 1,747 million, growing 15.7% YoY & 19.6% QoQ
  • First $100+ million quarterly revenue
  • Revenue per employee (RPE) crossing $70k
  • Secured several breakthrough deal wins with customer contracts exceeding $10 million ACV each
INDGN
Healthcare Research- Analytics & Technology
Indegene Ltd

Price Impact